Not Rated
|
Fund Size
(0.09% of Investment in Category)
|
Expense Ratio
(0.89% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 04-Nov-25 | 9876.80 | -1.23% | - | -0.36% | 205/231 |
| 1 Month | 10-Oct-25 | 9997.10 | -0.03% | - | 0.94% | 169/227 |
| 3 Month | 11-Aug-25 | 10100.10 | 1.00% | - | 4.69% | 212/224 |
| 6 Month | 09-May-25 | 10827.50 | 8.28% | - | 11.50% | 167/213 |
| YTD | 01-Jan-25 | 9597.60 | -4.02% | - | 4.88% | 177/201 |
| 1 Year | 11-Nov-24 | 10162.30 | 1.62% | 1.62% | 5.15% | 134/187 |
| Since Inception | 12-Dec-23 | 14026.00 | 40.26% | 19.29% | 14.09% | 52/199 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 11-Nov-24 | 12000 | 12483.72 | 4.03 % | 7.52 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 605.8 | 13.05% | 0.07% | 17.91% (Mar 2025) | 12.98% (Aug 2025) | 3.80 L | 0.00 |
| Max Healthcare Institute Ltd. | Hospital | 340 | 7.33% | -0.21% | 8.58% (Jun 2025) | 3.91% (Nov 2024) | 3.05 L | 0.00 |
| J.b. Chemicals & Pharmaceuticals Ltd. | Pharmaceuticals | 275.3 | 5.93% | -0.02% | 5.95% (Aug 2025) | 3.34% (Oct 2024) | 1.61 L | 0.00 |
| Cipla Ltd. | Pharmaceuticals | 255.6 | 5.51% | -0.28% | 7.08% (Oct 2024) | 4.81% (Jul 2025) | 1.70 L | 0.00 |
| Divis Laboratories Ltd. | Pharmaceuticals | 227.6 | 4.90% | -0.35% | 6.09% (May 2025) | 4.83% (Jan 2025) | 40.00 k | 0.00 |
| Apollo Hospitals Enterprises Ltd. | Hospital | 196.3 | 4.23% | -0.09% | 4.32% (Aug 2025) | 3.17% (May 2025) | 26.50 k | 0.00 |
| Fortis Healthcare Ltd. | Hospital | 194 | 4.18% | 0.28% | 4.18% (Sep 2025) | 1.85% (Jan 2025) | 2.00 L | 0.00 |
| Lupin Ltd. | Pharmaceuticals | 181.6 | 3.91% | 0.05% | 3.91% (Sep 2025) | 2.86% (Jul 2025) | 95.00 k | 0.00 |
| Jubilant Life Sciences Ltd. | Pharmaceuticals | 151.1 | 3.26% | 0.19% | 4.18% (Oct 2024) | 3.04% (Apr 2025) | 1.40 L | 0.00 |
| Krishna Institute of Medical Sciences Ltd. | Hospital | 140 | 3.02% | 0.69% | 3.02% (Sep 2025) | 2.01% (Oct 2024) | 2.00 L | 50.00 k |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 2.56% |
| Net Receivables | Net Receivables | -0.24% |
Ratios calculated on daily returns for last 3 years (Updated as on 01st January, 1970)
No data available. Ratios are only available for the funds which are 3 years old.
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund - Direct Plan - Growth | NA | 421.51 | 1.23 | 15.73 | 53.96 | 40.74 | 38.90 |
| Aditya Birla Sun Life International Equity Fund - Direct Plan - Growth | NA | 273.51 | 2.31 | 5.74 | 19.20 | 28.72 | 16.90 |
| Quant BFSI Fund - Direct Plan - Growth | NA | 655.17 | 4.03 | 7.83 | 25.70 | 23.32 | 0.00 |
| HDFC Transportation and Logistics Fund - Direct Plan - Growth | NA | 1651.55 | 0.54 | 12.24 | 28.64 | 21.74 | 0.00 |
| Franklin Asian Equity Fund - Direct - Growth | NA | 279.13 | 2.21 | 11.24 | 23.52 | 21.46 | 15.05 |
| Nippon India Japan Equity Fund - Direct Plan - Growth | NA | 292.35 | 1.47 | 4.07 | 12.97 | 19.61 | 18.10 |
| DSP Banking & Financial Services Fund - Direct Plan - Growth | NA | 1419.62 | 2.89 | 6.92 | 12.25 | 18.55 | 0.00 |
| ITI Banking and Financial Services Fund - Direct Plan - Growth | NA | 333.18 | 4.09 | 7.72 | 12.34 | 18.52 | 15.35 |
| SBI Banking & Financial Services Fund - Direct Plan - Growth | NA | 9273.44 | 2.64 | 5.70 | 13.80 | 17.27 | 20.36 |
| HDFC Defence Fund - Direct Plan - Growth | NA | 7024.28 | 0.53 | 7.87 | 18.29 | 17.15 | 0.00 |
Out of 89 mutual fund schemes offered by this AMC, 8 is/are ranked 4 * , 9 is/are ranked 3 * , 7 is/are ranked 2 * , 2 is/are ranked 1 * , and 63 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Kotak Arbitrage Fund - Direct Plan - Growth | 3 | 72279.21 | 0.57 | 1.41 | 3.10 | 7.03 | 7.91 |
| Kotak Midcap Fund - Direct Plan - Growth | 4 | 58299.59 | -0.85 | 2.92 | 15.25 | 6.02 | 22.74 |
| Kotak Flexi Cap Fund - Direct Plan - Growth | 3 | 54083.13 | 0.81 | 4.09 | 10.05 | 9.01 | 17.39 |
| Kotak Liquid Fund - Direct Plan - Growth | 2 | 34080.38 | 0.49 | 1.46 | 3.05 | 6.75 | 7.07 |
| Kotak Money Market Fund - Direct Plan - Growth | 3 | 32820.86 | 0.51 | 1.50 | 3.48 | 7.66 | 7.64 |
| Kotak Large & Midcap Fund - Direct Plan - Growth | 3 | 29515.91 | 0.80 | 4.99 | 12.05 | 5.63 | 19.95 |
| Kotak Multicap Fund - Direct Plan - Growth | 4 | 21541.46 | 0.79 | 8.18 | 16.13 | 7.16 | 24.59 |
| Kotak Bond Short Term Plan - Direct Plan - Growth | 3 | 18155.54 | 0.57 | 1.62 | 3.52 | 8.49 | 8.08 |
| Kotak Corporate Bond Fund - Direct Plan - Growth | 3 | 17545.56 | 0.59 | 1.74 | 3.72 | 8.67 | 8.14 |
| Kotak Small Cap Fund - Direct Plan - Growth | 2 | 17480.17 | -0.99 | 0.75 | 9.34 | -5.45 | 17.13 |